CLASS II Drug recall · Reported 15 Dec 2021 · FDA Enforcement Report
VANComycin added to of 0.9% Sodium Chloride (Injection recalled
Apollo Care is recalling VANComycin added to of 0.9% Sodium Chloride (Injection for Intravenous Use Only) per, distributed in Missouri. The recall was initiated on 28 Oct 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0277-2022
- FDA event ID
- 89011
- Recalling firm
- Apollo Care, Columbia, MO
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 28 Oct 2021
- FDA classified
- 8 Dec 2021
- Reported
- 15 Dec 2021
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Antibiotics
Timeline
| 28 Oct 2021 | Recall initiated by company | |
| 8 Dec 2021 | Classified by FDA | +41 days |
| 15 Dec 2021 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Crystallization: Product appears to be turbid.
Product as listed by the FDA
VANComycin 1g added to 250mL of 0.9% Sodium Chloride (Injection for Intravenous Use Only), 260 mL per bag, Rx Only, This is a Compounded Drug, Hospital/Office Use Only, Apollo Care 3801 Mojave Ct, Suite 101, Columbia, MO 65202, NDC 71170-254-25
Where it was distributed
MO
Questions about this recall
Why was it recalled?
Crystallization: Product appears to be turbid.
Which lots are affected?
Lot #: AC-016402, Exp 2/12/2022
Where was it sold?
MO
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Apollo Care
All 34| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Semaglutide 5mg (1mg/mL), Glycine 25 mg recalled by Apollo Care | Apollo Care | Particulate Matter | Nationwide |
| Drug | CLASS II | Semaglutide 4.5mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled | Apollo Care | Particulate Matter | Nationwide |
| Drug | CLASS II | Semaglutide 9mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled | Apollo Care | Particulate Matter | Nationwide |
| Drug | CLASS II | Semaglutide 10mg (5mg/mL), Glycine 10 mg recalled by Apollo Care | Apollo Care | Particulate Matter | Nationwide |
| Drug | CLASS II | Semaglutide 20mg (5mg/mL), Glycine 20 mg recalled by Apollo Care | Apollo Care | Particulate Matter | Nationwide |